NCT00002585View on ClinicalTrials.gov

Pyrazoloacridine in Treating Women With Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 1994

Primary Completion Date

October 31, 1999

Study Completion Date

January 31, 2001

Conditions
Breast Cancer
Interventions
DRUG

pyrazoloacridine

Trial Locations (1)

48201

Barbara Ann Karmanos Cancer Institute, Detroit

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Barbara Ann Karmanos Cancer Institute

OTHER

NCT00002585 - Pyrazoloacridine in Treating Women With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter